Trial record 19 of 24 for:    Open Studies | "Pheochromocytoma"

Adrenal Tumors - Pathogenesis and Therapy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by University of Wuerzburg.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Deutsche Krebshilfe e.V., Bonn (Germany)
German Federal Ministry of Education and Research
Information provided by:
University of Wuerzburg
ClinicalTrials.gov Identifier:
NCT00669266
First received: April 28, 2008
Last updated: July 6, 2010
Last verified: July 2010
  Purpose

The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.


Condition
Adrenal Tumors
Adrenocortical Carcinoma
Cushing Syndrome
Conn Syndrome
Pheochromocytoma

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen

Resource links provided by NLM:


Further study details as provided by University of Wuerzburg:

Biospecimen Retention:   Samples With DNA

Germline DNA Tumor samples Serum Plasma Urine


Estimated Enrollment: 500
Study Start Date: September 2002
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with adrenal tumors

Criteria

Inclusion Criteria:

  • adrenal tumor detected by imaging

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00669266

Contacts
Contact: Martin Fassnacht, MD 49-931-201-36507 fassnacht_m@medizin.uni-wuerzburg.de

Locations
Germany
University of Wuerzburg Recruiting
Wuerzburg, Germany, 97080
Contact: Martin Fassnacht, MD       fassnacht_m@medizin.uni-wuerzburg.de   
Contact: Stefanie Hahner, MD       hahner_s@medizin.uni-wuerzburg.de   
Principal Investigator: Martin Fassnacht, MD         
Sponsors and Collaborators
University of Wuerzburg
Deutsche Krebshilfe e.V., Bonn (Germany)
German Federal Ministry of Education and Research
Investigators
Principal Investigator: Martin Fassnacht, MD U of Wuerzburg
  More Information

No publications provided

Responsible Party: Martin Fassnacht, MD, University of Wuerzburg
ClinicalTrials.gov Identifier: NCT00669266     History of Changes
Other Study ID Numbers: Wue-Adrenal-Tumors-92/2002
Study First Received: April 28, 2008
Last Updated: July 6, 2010
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Pheochromocytoma
Syndrome
Adrenocortical Carcinoma
Cushing Syndrome
Adrenal Gland Neoplasms
Disease
Pathologic Processes
Paraganglioma
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Adenocarcinoma
Carcinoma
Neoplasms, Glandular and Epithelial
Adrenal Cortex Neoplasms
Endocrine Gland Neoplasms
Neoplasms by Site
Adrenal Cortex Diseases
Adrenal Gland Diseases
Endocrine System Diseases
Adrenocortical Hyperfunction

ClinicalTrials.gov processed this record on September 18, 2014